Back to search
Metastatic Seminoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Metastatic Seminoma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Metastatic Seminoma trials you may qualify forThis phase I trial evaluates whether adding Pedmark to standard of care cisplatin-based chemotherapy reduces drug-induced ear damage (ototoxicity) in men with s…
The goal of this prospective observational study is to learn about the short- and long-term effects of treating men over the age of 18 with good prognosis metas…
The purpose of the study is to evaluate the ration of patients getting an lighten therapeutic strategy after 18F-fluoro-désoxyglucose positron emission tomograp…
This phase II trial studies nivolumab and ipilimumab in treating patients with rare tumors. Immunotherapy with monoclonal antibodies, such as nivolumab and ipil…
This phase II trial studies how well retroperitoneal lymph node dissection (RPLND) works in treating patients with stage I-IIa testicular seminoma. The retroper…